DIFFERENT PRICES FOR THE SAME MEDICINE: A BIG WORRY

.art_img_class {width:200px;background:#f0f0f0;margin-top:1em;font-size:0.7em;display:none;} art_imgs = 0; cur_art_img = 1; function prev(){ for (i=1;i=art_imgs;i++){ document.getElementById("art_img_"+i).style.display = "none"; } if(cur_art_img==1){ cur_art_img = art_imgs; }else{ cur_art_img -= 1; } ...

Read More

The discovery of cancer drug cisplatin

Its origin had nothing to do with cancer or drug.  Biophysicist Barnett Rosenberg conceived the idea that electric currents may affect cell growth.  He designed an experiment that passed an electric current through a soup of chemical nutrients in which bacteria grew.  For electrodes he decided to...

Read More

The Sildenafil story(Viagra)

It would not become a drug for heart diseases, researchers at Pfizer sighed.  For years they worked on sildenafil, an inhibitor of the PDE5 enzyme, which they hoped would be effective in relaxing coronary arteries and relieving chest pain.  Their hope was dashed by 1992. Only one out of ten candidates entering clinical trials successfully passes through the gauntlet and reaches consumers, but statistics is little consolation for those who see their projects falling on the heap of nine.  Gloomily,...

Read More

GPAT quiz

 Here is the link to one of the most exclusive gpat questions!! all for you...  http://www.pharmainfo.net/gpat-quizzes And for the preparation of GPAT, you will get the perfect guidance here...... http://www.pharmatutor.org/exam-alert/prepare-for-pharma-entrances.html so, guys......njoy!!...

Read More

Indian Pharma players grab the opportunity as US Patent expiries enter the market

2010-12 period is the most lucrative for the Indian companies as 26 major drugs with total sales of $69 billion are set to lose patent protection. Recently, US Pharma market, although the world’s largest was seen dwindling as it grew a meagre 1-2% in 2009, in comparison to emerging economies in Asia and Latin America, such as Brazil, Turkey and Mexico which have been growing at a healthy 14-15% annually. But the impending patent expiries are set to turn the tide in favour of the US again. Though it is common knowledge that the price of the drug...

Read More

Pharma Block Busters: New US FDA drug Approvals: INDIA

Pharma Block Busters: New US FDA drug Approvals: INDIA Good news for the India Pharma Industry: Glenmark Pharmaceuticals has recieved FDA's approval for moexipril hydrochloride and hydrochlorothiazide tablets.The tablets are the generic version of Schwarz Pharmaceuticals' Uniretic and are used to treat Hypertension. This drug has annual sales of $8 million in the US.---------------------------------------------------------------------------------------------------- Another Indian Major, Sun Pharmaceutical Industries recieved the approval...

Read More

Pharma block Busters

Hello friends!!Namaste to all the Pharmacists of today, the upcoming Pharmacists and all those who love Blogging. Just as i am writing this blog, i feel the need for more pharma blogs.....as blogs concerned with pharma world are far too few. And if the technology provides us an opportunity then why to waste ......This blog is exclusively for the Pharmacists....so,...

Read More